Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer

Overview of attention for article published in Prostate Cancer and Prostatic Diseases, August 2005

Altmetric Badge

Mentioned by

patent: 1 patent

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 1 patent that references this research output.

TUMOUR MICROBIOME ANALYSIS AS A PROGNOSTIC INDICATOR OF PROSTATE CANCER

Application WO-2023139137-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.